Accent Microcell Limited (NSE:ACCENTMIC)

Market Cap	9.49B +114.9%
Revenue (ttm)	3.56B +34.3%
Net Income	438.59M +32.7%
EPS	18.65 +18.7%
Shares Out	21.04M
PE Ratio	24.18
Forward PE	n/a
Dividend	1.00 (0.22%)
Ex-Dividend Date	Sep 16, 2025

Volume	47,500
Open	450.00
Previous Close	446.15
Day's Range	448.05 - 461.00
52-Week Range	215.10 - 481.00
Beta	0.31
Analysts	n/a
Price Target	n/a
Earnings Date	May 12, 2026

About Accent Microcell

Accent Microcell Limited manufactures, sells, and trades in cellulose-based excipients for the pharmaceutical industry in India and internationally. The company offers microcrystalline cellulose, powdered cellulose, microcrystalline cellulose spheres, silicified microcrystalline cellulose, crosscarmellose sodium, magnesium stearate, and microcrystalline cellulose with carboxy methyl cellulose. It also provides services, including supply chain management, on-time material delivery, customer assistance, and quality commitment. The company sells i...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 2001
• Employees: 192
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ACCENTMIC

Financial Performance

In fiscal year 2026, Accent Microcell's revenue was 3.56 billion, an increase of 34.33% compared to the previous year's 2.65 billion. Earnings were 438.59 million, an increase of 32.65%.